SCHEMBL23320218

SCHEMBL23320218

C=C(C)/C(C)=C(C)/C=C(\C=N)c1cccc(C)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ KCNK3 O14649 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ KCNK9 Q9NPC2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ FAAH O00519 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ ACHE P22303 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ CTNNB1 P35222 1/20 0.31
▸ WNT3A P56704 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17468521 0.78 PARP1 (0.41) PARP1HDAC8HDAC6SMN1; SMN2TDP1
SCHEMBL23260541 0.76 PARP1 (0.47) PARP1HDAC8HDAC6SMN1; SMN2TDP1
SCHEMBL23319685 0.75 KDM4E (0.34) PARP1HDAC8HDAC6TDP1HPGD
SCHEMBL17034487 0.73 PARP1 (0.42) PARP1HDAC8HDAC6SMN1; SMN2TDP1
SCHEMBL24711679 0.73 PARP1 (0.48) PARP1HDAC8HDAC6SMN1; SMN2TDP1
SCHEMBL24711143 0.72 PARP1 (0.47) PARP1HDAC8HDAC6SMN1; SMN2TDP1
SCHEMBL20037381 0.70 HDAC8 (0.43) PARP1HDAC8HDAC6SMN1; SMN2TDP1
SCHEMBL610252 0.67 PARP1 (0.54) PARP1HDAC8HDAC6SMN1; SMN2TDP1
SCHEMBL29444189 0.67 PARP1 (0.54) PARP1HDAC8HDAC6SMN1; SMN2TDP1
SCHEMBL15471903 0.67 PARP1 (0.46) PARP1HDAC8HDAC6SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021087144-A1 THERAPEUTIC METHODS USING VADADUSTAT AKEBIA THERAPEUTICS, INC. (US) 2021-05-06 — — WO disclosed
Send feedback